Table 4.
Frequency of Maternal Thyroid Medication Use by Type of Thyroid Medication and Timing of Use among Controls (n = 5875) and Cases (n = 14,067), National Birth Defects Prevention Study, 1997–2004a
| Controlsb | Cases | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
| Timing of use during pregnancyc | Timing of use during pregnancyc | |||||||
|
|
|
|||||||
| Early | Late | Unknown | Total | Early | Late | Unknown | Total | |
| Any thyroid medications | 100 | 2 | 1 | 103 | 289 | 5 | 1 | 295 |
| Thyroxine | 94 | 0 | 1 | 95 | 266 | 1 | 1 | 268 |
| Antithyroid medication | 5 | 2 | 0 | 7 | 20 | 3 | 0 | 23 |
| Unknown thyroid medication | 2 | 0 | 0 | 2 | 3 | 1 | 0 | 4 |
Case counts are for all birth defect categories included in the present analysis. Eight control and 21 case mothers reported thyroid disease, but no thyroid medication use during the period 3 months before conception through the end of pregnancy.
One control mother reported taking both thyroxine and an antithyroid medication.
Early use is defined as any use three months before conception through the end of the first trimester. Late use is defined as use only during pregnancy month four through delivery. Unknown is defined as insufficient information to determine timing of use.